Trial Information
Genetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid Leukemia
Inclusion Criteria:
- patients with acute myeloid leukemia
- 15 years or older
- patients treated with induction/consolidation chemotherapy
- patients with available bone marrow sample
Exclusion Criteria:
- acute biphenotypic leukemia
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Principal Investigator
Dong Hwan Kim, M.D., Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Samsung Medical Center
Authority:
South Korea: Institutional Review Board
Study ID:
2008-08-094
NCT ID:
NCT01106144
Start Date:
May 2010
Completion Date:
Related Keywords:
- Patients With Acute Myeloid Leukemia
- Patients Receiving Induction/Consolidation Chemotherapy
- Leukemia
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid